A Phase 2 interventional study of CX11 in Type 2 Diabetes

Recruiting Phase 2 NCT07340320

Study Description

Testing CX11 tablets to improve blood sugar control in people with type 2 diabetes who aren't well-controlled on current medications

Study Details

Registry ID:
NCT07340320
Conditions:
Type II Diabetes Mellitus
Phase:
Phase 2
Target Enrollment:
240 participants
Start Date:
Healthy Volunteers:
No

Study Locations (48 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →